NCT06133244 Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
| NCT ID | NCT06133244 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UMC Utrecht |
| Condition | Systemic Sclerosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2024-04-19 |
| Primary Completion | 2028-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2024-04-19 with a primary completion date of 2028-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Almost 90% of systemic sclerosis (SSc) patients experience hand function limitation, which leads to impaired daily functioning and work participation. An important cause of impaired hand function are contractures of the hand, which are reported in up to a half of patients. With this longitudinal cohort study in patients with SSc and VEDOSS (very early diagnosis of systemic sclerosis) the investigators aim to gain more insight into processes involved in hand function impairment.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years Exclusion Criteria: * Patients with diabetic cheiroarthropathy and Dupuytren's disease, based on expert opinion
Frequently Asked Questions
Who can join the NCT06133244 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Systemic Sclerosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06133244 currently recruiting?
Yes, NCT06133244 is actively recruiting participants. Visit ClinicalTrials.gov or contact UMC Utrecht to inquire about joining.
Where is the NCT06133244 trial being conducted?
This trial is being conducted at Utrecht, Netherlands.
Who is sponsoring the NCT06133244 clinical trial?
NCT06133244 is sponsored by UMC Utrecht. The trial plans to enroll 300 participants.